Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Julio Cesar Sanchez Avalos"'
Autor:
Carolina Pavlovsky, Bianca Vasconcelos Cordoba, María Belén Sanchez, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, Maria Josefina Freitas, Maria Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Angel Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, Jose Mordoh, Julio Cesar Sanchez Avalos, Gerardo Cueto, Silvia Miranda, Estrella Mariel Levy, Michele Bianchini
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-4 (2023)
Abstract Treatment-free remission (TFR) in chronic myeloid leukemia (CML) is safe under adequate molecular monitoring, but questions remain regarding which factors may be considered predictive for TFR. Argentina Stop Trial (AST) is a multicenter TFR
Externí odkaz:
https://doaj.org/article/8fe9929083cf47d5a46398245f9bd84d
Autor:
María Belén Sanchez, Bianca Vasconcelos Cordoba, Carolina Pavlovsky, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, María Josefina Freitas, María Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Arturo Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, José Mordoh, Julio Cesar Sanchez Avalos, Estrella Mariel Levy, Michele Bianchini
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTreatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is available. However, the question arises as to which factors can contribute to the ma
Externí odkaz:
https://doaj.org/article/c31cf40a2c9d4dd98ac2f1617ee73530
Autor:
Romina Gamberale, Gonzalo Martín Garate, Mirta Giordano, Mercedes Borge, Esteban Enrique Elías, Julio Cesar Sanchez Avalos, Raimundo F. Bezares, Valeria Judith Sarapura Martinez, Miguel A. Pavlovsky, Gregorio Cordini, Ana Colado, Horacio Fernandez Grecco, Mikele Amondarain, Maria del Rosario Custidiano
Publikováno v:
Cancer Immunology, Immunotherapy. 71:979-987
Venetoclax treatment has demonstrated efficacy and a safety profile in chronic lymphocytic leukemia (CLL) patients, however the emergence of resistant cells is a current complication. We and others, previously reported that the activation of CLL cell
Autor:
Ricardo Khalil Khalil Tannuri, Beatriz Moiraghi, Miguel Arturo Pavlovsky, Ana Ines Varela, Michele Bianchini, Isabel Giere, Isolda I. Fernandez, Georgina Bendek, Romina Mariano, Josefina Freitas, Veronica Ventriglia, Maria Del Rosario Custidiano, Ana Garcia de Labanca, Julio Cesar Sanchez Avalos, Maria J. Mela Osorio, Bianca Vasconcelos Cordoba, Maria Belen Sanchez, Mariana Juni, Marcos Bianco, Carolina Pavlovsky
Publikováno v:
Blood. 140:5088-5089
Autor:
Josefina Freitas, Daniel Koile, Simone Bonecker, Veronica Ventriglia, Jose Mordoh, Ilana Zalcberg, Michele Bianchini, Julio Cesar Sanchez Avalos, María Sol Ruiz, Carolina Furtado, Beatriz Moiraghi, Irene Larripa, Ana Ines Varela, Peter Valent, Maria Belen Sanchez, Patricio Yankilevich, Santiago Cranco, Maria Del Rosario Custidiano, Carolina Pavlovsky, Mariel Ana Perez
Chronic myeloid leukemia (CML) is a myeloid stem cell neoplasm characterized by an expansion of myeloid progenitor cells and the presence of BCR-ABL1 oncoprotein. Since the introduction of specific BCR-ABL1 tyrosine kinase inhibitors (TKI), overall s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e429f3fbf5a97389004755abc65010e
Autor:
Patricio Yankilevich, Celeste Mosqueira, Cecilia Foncuberta, Beatriz Moiraghi, Josefina Freitas, Daniel Koile, Irene Larripa, Veronica Ventriglia, Jose Mordoh, Maria Belen Sanchez, Julio Cesar Sanchez Avalos, Carolina Pavlovsky, Leandro German Gutierrez, Michele Bianchini, Maria Del Rosario Custidiano, Santiago Cranco, Mariel Ana Perez, María Sol Ruiz
Publikováno v:
Oncotarget
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Quantification of BCR-ABL1 mRNA levels in peripheral blood of chronic myeloidleukemia patients is a strong indicator of response to tyrosine-kinase inhibitors (TKI)treatment. However, additional prognostic markers are needed in order to better classi
Autor:
Laura Korin, Maria Lucia Fuente, Santiago Cranco, Paola Ochoa, Adriana Vitriu, Evelina Babuin, Anahí Vijnovich Baron, Maria Belen Venegas, Paula Tempra, Andrea Novoa, Norma Elisabeth Tartas, Maria Del Rosario Custidiano, Maria Cecilia Foncuberta, Julio Cesar Sanchez Avalos
Publikováno v:
Blood. 138:2415-2415
INTRODUCTION Tumor microenvironment (TME) in diffuse large B-cell lymphoma (DLBCL) has recently been in the spotlight. The predictive role of immune cells (IC) in peripheral blood (PB), bone marrow (BM) and lymph nodes (LN) has been individually asse
Autor:
Adriana Vitriu, Fernando Diaz Couselo, Maria Belen Venegas, Anahí Vijnovich Baron, Santiago Cranco, Maria Cecilia Foncuberta, Laura Korin, Maria Lucia Fuente, Julio Cesar Sanchez Avalos, Paula Tempra, N Tartas, Evelina Babuin, Andrea Novoa, Maria Del Rosario Custidiano, Paola Ochoa
Publikováno v:
Blood. 136:23-23
INTRODUCTION: Several studies have disclosed the predictive role of tumor microenvironment (ME) in diffuse large B cell lymphoma (DLBCL). However, there is limited data regarding the prognostic impact of immune cells (IC) in the bone marrow (BM) of D
Autor:
Beatriz Moiraghi, Romina Mariano, María Jose Mela Osorio, Julio Cesar Sanchez Avalos, Maria Cecilia Foncuberta, Josefina Freitas, Miguel A. Pavlovsky, Maria Del Rosario Custidiano, Estrella Mariel Levy, Michele Bianchini, Bianca Vasconcelos Cordoba, Mariana Juni, Carolina Pavlovsky, Veronica Ventriglia, Ana Ines Varela, Maximiliano Luis Riddick, Isolda Fernandez, Ana Garcia de Labanca, Maria Belen Sanchez, Jose Mordoh, Masiel Vera, Isabel Giere, Georgina Bendek
Publikováno v:
Blood. 136:24-24
INTRODUCTION: Long-term survival of patients with chronic myeloid leukemia (CML) has significantly improved since the introduction of BCR-ABL1 tyrosine kinase inhibitors (TKIs). Several considerations about the side effects, risks and cost associated
Autor:
N Tartas, Maria Del Rosario Custidiano, Maria Lucia Fuente, Julio Cesar Sanchez Avalos, Paula Tempra, Evelina Babuin, Santiago Cranco, Laura Korin, Anahí Vijnovich Baron, Andrea Novoa, Paola Ochoa, Maria Cecilia Foncuberta, Maria Belen Venegas, Adriana Vitriu, Fernando Diaz Couselo
Publikováno v:
Blood. 134:1625-1625
INTRODUCTION: Recent studies have suggested that tumor microenviroment (TME) may play an important role in lymphomagenesis and tumor progression in non-Hodgkin lymphoma. Tumor-infiltrating lymphocytes and myeloid-derived cells could provide valuable